Hoda Samir

Dr. Hoda Samir


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RRRogy reda
Rogy reda
MSMarwa A. Saleh
Marwa A. Saleh
SASefat A. Alwarsh
Sefat A. Alwarsh
ARAreej Rushdi
Areej Rushdi
AAAzza Ali Althoqapy
Azza Ali Althoqapy
AMAyman Mohamed
Ayman Mohamed
Herein, a series of new isatin derivatives was designed and synthesized (1–9) as broad-spectrum antiviral agents. Consequently, the antiviral activities of the synthesized compounds (1–9) were pursued against three viruses, namely influenza virus (H1N1), herpes simplex virus 1 (HSV-1), and coxsackievirus B3 (COX-B3). In particular, compounds 9, 5, and 4 displayed the highest antiviral activity against H1N1, HSV-1, and COX-B3 with IC50 values of 0.0027, 0.0022, and 0.0092 µM, respectively. Compound 7 was the safest, with a CC50 value of 315,578.68 µM. Moreover, a quantitative PCR (real-time PCR) assay was carried out for the most relevant compounds. The selected compounds exhibited a decrease in viral gene expression. Additionally, the conducted in silico studies emphasized the binding affinities of the synthesized compounds and their reliable pharmacokinetic properties as well. Finally, a structure–antiviral activity relationship study was conducted to anticipate the antiviral activity change upon future structural modification.

7 February 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RRRogy reda
Rogy reda
MSMarwa A. Saleh
Marwa A. Saleh
SASefat A. Alwarsh
Sefat A. Alwarsh
ARAreej Rushdi
Areej Rushdi
AAAzza Ali Althoqapy
Azza Ali Althoqapy
AMAyman Mohamed
Ayman Mohamed
The Pharmaceuticals Editorial Office retracts the article “Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure–Activity Relationship Studies”